Literature DB >> 18068129

Parallel increase in p70 kinase activation and tau phosphorylation (S262) with Abeta overproduction.

Xin-Wen Zhou1, Heikki Tanila, Jin-Jing Pei.   

Abstract

This study set out to search for a link between overproduction of Abeta and p70S6 kinase (p70S6K) phosphorylation/activation. Results showed that levels of p-p70S6K at T421/S424 and T389 are significantly increased in mouse N2a neuroblastoma cells carrying human APP with Swedish mutation (APPswe), and in transgenic APPswe/PS1 (A246E) mice as compared with respective controls, corresponding to the increase of tau phosphorylation at S262. This parallel increase in p70S6K activation and tau phosphorylation could be demonstrated by treating wild-type N2a cells with Abeta25-35. Our results suggest that the Abeta deposition in senile plaques in Alzheimer disease brains might be a primary event that activates p70S6K and phosphorylates tau at S262, resulting in microtubule disruption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068129     DOI: 10.1016/j.febslet.2007.11.078

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Functional role of RNA polymerase II and P70 S6 kinase in KCl withdrawal-induced cerebellar granule neuron apoptosis.

Authors:  Jaya Padmanabhan; Kristy R Brown; Amelia Padilla; Michael L Shelanski
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

Review 2.  Targeting the mTOR signaling network for Alzheimer's disease therapy.

Authors:  Chong Wang; Jin-Tai Yu; Dan Miao; Zhong-Chen Wu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-07-14       Impact factor: 5.590

3.  Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

Authors:  Antonella Caccamo; Caterina Branca; Joshua S Talboom; Darren M Shaw; Dharshaun Turner; Luyao Ma; Angela Messina; Zebing Huang; Jie Wu; Salvatore Oddo
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

Review 4.  mTOR-dependent signalling in Alzheimer's disease.

Authors:  Jin-Jing Pei; Jacques Hugon
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

5.  High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction.

Authors:  Jing Wu; Shan-Lei Zhou; Lin-Hua Pi; Xia-Jie Shi; Ling-Ran Ma; Zi Chen; Min-Li Qu; Xin Li; Sheng-Dan Nie; Duan-Fang Liao; Jin-Jing Pei; Shan Wang
Journal:  Oncotarget       Date:  2017-06-20

Review 6.  Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.

Authors:  Sima Kianpour Rad; Aditya Arya; Hamed Karimian; Priya Madhavan; Farzana Rizwan; Shajan Koshy; Girish Prabhu
Journal:  Drug Des Devel Ther       Date:  2018-11-22       Impact factor: 4.162

7.  Yizhiqingxin Formula Alleviates Cognitive Deficits and Enhances Autophagy via mTOR Signaling Pathway Modulation in Early Onset Alzheimer's Disease Mice.

Authors:  Yang Yang; Zhiyong Wang; Yu Cao; Jiangang Liu; Peng Li; Hao Li; Meixia Liu
Journal:  Front Pharmacol       Date:  2019-09-17       Impact factor: 5.810

8.  Machine learning identifies candidates for drug repurposing in Alzheimer's disease.

Authors:  Steve Rodriguez; Clemens Hug; Petar Todorov; Nienke Moret; Sarah A Boswell; Kyle Evans; George Zhou; Nathan T Johnson; Bradley T Hyman; Peter K Sorger; Mark W Albers; Artem Sokolov
Journal:  Nat Commun       Date:  2021-02-15       Impact factor: 14.919

Review 9.  Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.

Authors:  Gabriela Dumitrita Stanciu; Razvan Nicolae Rusu; Veronica Bild; Leontina Elena Filipiuc; Bogdan-Ionel Tamba; Daniela Carmen Ababei
Journal:  Biomedicines       Date:  2021-05-19

Review 10.  The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease.

Authors:  Joshua S Talboom; Ramon Velazquez; Salvatore Oddo
Journal:  NPJ Aging Mech Dis       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.